Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product

Haim Werner, Gian G. Re, Iain A. Drummond, Vikas P. Sukhatme, Frank J. Rauscher, Donald A. Sens, A. Julian Garvin, Derek Leroith, Charles Roberts

Research output: Contribution to journalArticle

253 Citations (Scopus)

Abstract

Wilms tumor is a pediatric neoplasm that arises from the metanephric blastema. The expression of the gene encoding insulin-like growth factor II (IGF-II) is often elevated in these tumors. Since many of the actions of IGF-II are mediated through activation of the IGF-I receptor (IGF-IR), we have measured the levels of IGF-IR mRNA in normal kidney and in Wilms tumor samples using solution hybridization/RNase protection assays. IGF-IR mRNA levels in the tumors were 5.8-fold higher than in adjacent normal kidney tissue. Among the tumors themselves, the levels of IGF-IR mRNA in those containing heterologous stromal elements were 2-fold higher (P <0.01) than in tumors without these elements. IGF-IR gene (designated IGF1R) expression in the tumors was inversely correlated with the expression of the Wilms tumor suppressor gene WT1, whose inactivation appears to be a key step in the etiology of Wilms tumor. Cotransfection of Chinese hamster ovary cells with rat and human IGF-IR gene promoter constructs driving luciferase reporter genes and with WT1 expression vectors showed that the active WT1 gene product represses IGF-IR promoter activity in a dose-dependent manner. These results suggest that underexpression, deletion, or mutation of WT1 may result in increased expression of the IGF-IR, whose activation by IGF-II may be an important aspect of the biology of Wilms tumor.

Original languageEnglish (US)
Pages (from-to)5828-5832
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume90
Issue number12
StatePublished - Jun 15 1993
Externally publishedYes

Fingerprint

Wilms' Tumor Genes
IGF Type 1 Receptor
Wilms Tumor
Genes
Insulin-Like Growth Factor II
Neoplasms
Messenger RNA
Kidney
Sequence Deletion
Ribonucleases
Cricetulus
Tumor Suppressor Genes
Luciferases
Reporter Genes
Ovary
Pediatrics
Gene Expression

ASJC Scopus subject areas

  • General
  • Genetics

Cite this

Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product. / Werner, Haim; Re, Gian G.; Drummond, Iain A.; Sukhatme, Vikas P.; Rauscher, Frank J.; Sens, Donald A.; Garvin, A. Julian; Leroith, Derek; Roberts, Charles.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 90, No. 12, 15.06.1993, p. 5828-5832.

Research output: Contribution to journalArticle

Werner, Haim ; Re, Gian G. ; Drummond, Iain A. ; Sukhatme, Vikas P. ; Rauscher, Frank J. ; Sens, Donald A. ; Garvin, A. Julian ; Leroith, Derek ; Roberts, Charles. / Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product. In: Proceedings of the National Academy of Sciences of the United States of America. 1993 ; Vol. 90, No. 12. pp. 5828-5832.
@article{7d6972a2e60c40b6a606e01e1ab6cecc,
title = "Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product",
abstract = "Wilms tumor is a pediatric neoplasm that arises from the metanephric blastema. The expression of the gene encoding insulin-like growth factor II (IGF-II) is often elevated in these tumors. Since many of the actions of IGF-II are mediated through activation of the IGF-I receptor (IGF-IR), we have measured the levels of IGF-IR mRNA in normal kidney and in Wilms tumor samples using solution hybridization/RNase protection assays. IGF-IR mRNA levels in the tumors were 5.8-fold higher than in adjacent normal kidney tissue. Among the tumors themselves, the levels of IGF-IR mRNA in those containing heterologous stromal elements were 2-fold higher (P <0.01) than in tumors without these elements. IGF-IR gene (designated IGF1R) expression in the tumors was inversely correlated with the expression of the Wilms tumor suppressor gene WT1, whose inactivation appears to be a key step in the etiology of Wilms tumor. Cotransfection of Chinese hamster ovary cells with rat and human IGF-IR gene promoter constructs driving luciferase reporter genes and with WT1 expression vectors showed that the active WT1 gene product represses IGF-IR promoter activity in a dose-dependent manner. These results suggest that underexpression, deletion, or mutation of WT1 may result in increased expression of the IGF-IR, whose activation by IGF-II may be an important aspect of the biology of Wilms tumor.",
author = "Haim Werner and Re, {Gian G.} and Drummond, {Iain A.} and Sukhatme, {Vikas P.} and Rauscher, {Frank J.} and Sens, {Donald A.} and Garvin, {A. Julian} and Derek Leroith and Charles Roberts",
year = "1993",
month = "6",
day = "15",
language = "English (US)",
volume = "90",
pages = "5828--5832",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "12",

}

TY - JOUR

T1 - Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product

AU - Werner, Haim

AU - Re, Gian G.

AU - Drummond, Iain A.

AU - Sukhatme, Vikas P.

AU - Rauscher, Frank J.

AU - Sens, Donald A.

AU - Garvin, A. Julian

AU - Leroith, Derek

AU - Roberts, Charles

PY - 1993/6/15

Y1 - 1993/6/15

N2 - Wilms tumor is a pediatric neoplasm that arises from the metanephric blastema. The expression of the gene encoding insulin-like growth factor II (IGF-II) is often elevated in these tumors. Since many of the actions of IGF-II are mediated through activation of the IGF-I receptor (IGF-IR), we have measured the levels of IGF-IR mRNA in normal kidney and in Wilms tumor samples using solution hybridization/RNase protection assays. IGF-IR mRNA levels in the tumors were 5.8-fold higher than in adjacent normal kidney tissue. Among the tumors themselves, the levels of IGF-IR mRNA in those containing heterologous stromal elements were 2-fold higher (P <0.01) than in tumors without these elements. IGF-IR gene (designated IGF1R) expression in the tumors was inversely correlated with the expression of the Wilms tumor suppressor gene WT1, whose inactivation appears to be a key step in the etiology of Wilms tumor. Cotransfection of Chinese hamster ovary cells with rat and human IGF-IR gene promoter constructs driving luciferase reporter genes and with WT1 expression vectors showed that the active WT1 gene product represses IGF-IR promoter activity in a dose-dependent manner. These results suggest that underexpression, deletion, or mutation of WT1 may result in increased expression of the IGF-IR, whose activation by IGF-II may be an important aspect of the biology of Wilms tumor.

AB - Wilms tumor is a pediatric neoplasm that arises from the metanephric blastema. The expression of the gene encoding insulin-like growth factor II (IGF-II) is often elevated in these tumors. Since many of the actions of IGF-II are mediated through activation of the IGF-I receptor (IGF-IR), we have measured the levels of IGF-IR mRNA in normal kidney and in Wilms tumor samples using solution hybridization/RNase protection assays. IGF-IR mRNA levels in the tumors were 5.8-fold higher than in adjacent normal kidney tissue. Among the tumors themselves, the levels of IGF-IR mRNA in those containing heterologous stromal elements were 2-fold higher (P <0.01) than in tumors without these elements. IGF-IR gene (designated IGF1R) expression in the tumors was inversely correlated with the expression of the Wilms tumor suppressor gene WT1, whose inactivation appears to be a key step in the etiology of Wilms tumor. Cotransfection of Chinese hamster ovary cells with rat and human IGF-IR gene promoter constructs driving luciferase reporter genes and with WT1 expression vectors showed that the active WT1 gene product represses IGF-IR promoter activity in a dose-dependent manner. These results suggest that underexpression, deletion, or mutation of WT1 may result in increased expression of the IGF-IR, whose activation by IGF-II may be an important aspect of the biology of Wilms tumor.

UR - http://www.scopus.com/inward/record.url?scp=0027278677&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027278677&partnerID=8YFLogxK

M3 - Article

VL - 90

SP - 5828

EP - 5832

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 12

ER -